» Articles » PMID: 37057639

Probing Mutation-induced Conformational Transformation of the GTP/M-RAS Complex Through Gaussian Accelerated Molecular Dynamics Simulations

Overview
Specialty Biochemistry
Date 2023 Apr 14
PMID 37057639
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations highly affect the structural flexibility of two switch domains in M-RAS considered an important target of anticancer drug design. Gaussian accelerated molecular dynamics (GaMD) simulations were applied to probe the effect of mutations P40D, D41E, and P40D/D41E/L51R on the conformational transition of the switch domains from the GTP-bound M-RAS. The analyses of free energy landscapes (FELs) not only reveal that three mutations induce less energetic states than the wild-type (WT) M-RAS but also verify that the switch domains are extremely disordered. Principal component analysis (PCA) and dynamics analysis suggest that three mutations greatly affect collective motions and structural flexibility of the switch domains that mostly overlap with binding regions of M-RAS to its effectors, which in turn disturbs the activity of M-RAS. The analyses of the interaction network between GTP and M-RAS show that the high instability in hydrogen bonding interactions (HBIs) of GTP with residue 41 and Y42 in the switch domain I drives the disordered states of the switch domains. This work is expected to provide a molecular mechanism for deeply understanding the function of M-RAS and future drug design towards the treatment of cancers.

Citing Articles

Binding Mechanism of Inhibitors to CDK6 Deciphered by Multiple Independent Molecular Dynamics Simulations and Free Energy Predictions.

Wang L, Wang Y, Zhang L, Zhao J, Wu S, Yang Z Molecules. 2025; 30(5).

PMID: 40076203 PMC: 11901890. DOI: 10.3390/molecules30050979.


Identifying Inhibitor-SARS-CoV2-3CL Binding Mechanism Through Molecular Docking, GaMD Simulations, Correlation Network Analysis and MM-GBSA Calculations.

Chen J, Wang J, Yang W, Zhao L, Xu X Molecules. 2025; 30(4).

PMID: 40005117 PMC: 11857935. DOI: 10.3390/molecules30040805.


Stereo-selectivity of enantiomeric inhibitors to ubiquitin-specific protease 7 (USP7) dissected by molecular docking, molecular dynamics simulations, and binding free energy calculations.

Zhang Y, Dou W, Zhao Z, Li G, Li C, Chen X Mol Divers. 2024; 29(2):1725-1735.

PMID: 39298085 DOI: 10.1007/s11030-024-10948-z.


Identification of potential NUDT5 inhibitors from marine bacterial natural compounds via molecular dynamics and free energy landscape analysis.

Dubey A, Alanazi A, Bhardwaj R, Ragusa A Mol Divers. 2024; .

PMID: 39225905 DOI: 10.1007/s11030-024-10950-5.


In silico discovery of potential PPI inhibitors for anti-lung cancer activity by targeting the CCND1-CDK4 complex via the P21 inhibition mechanism.

Tang W, Shen T, Chen Z Front Chem. 2024; 12:1404573.

PMID: 38957406 PMC: 11217521. DOI: 10.3389/fchem.2024.1404573.


References
1.
Wang J, Lan L, Wu X, Xu L, Miao Y . Mechanism of RNA recognition by a Musashi RNA-binding protein. Curr Res Struct Biol. 2022; 4:10-20. PMC: 8695263. DOI: 10.1016/j.crstbi.2021.12.002. View

2.
Miao Y, Feher V, McCammon J . Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation. J Chem Theory Comput. 2015; 11(8):3584-3595. PMC: 4535365. DOI: 10.1021/acs.jctc.5b00436. View

3.
Chen J, Zhang S, Wang W, Sun H, Zhang Q, Liu X . Binding of Inhibitors to BACE1 Affected by pH-Dependent Protonation: An Exploration from Multiple Replica Gaussian Accelerated Molecular Dynamics and MM-GBSA Calculations. ACS Chem Neurosci. 2021; 12(14):2591-2607. DOI: 10.1021/acschemneuro.0c00813. View

4.
Bao H, Wang W, Sun H, Chen J . Binding modes of GDP, GTP and GNP to NRAS deciphered by using Gaussian accelerated molecular dynamics simulations. SAR QSAR Environ Res. 2023; 34(1):65-89. DOI: 10.1080/1062936X.2023.2165542. View

5.
Carratt S, Braun T, Coblentz C, Schonrock Z, Callahan R, Curtiss B . Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. Leukemia. 2022; 36(8):2149. DOI: 10.1038/s41375-022-01646-6. View